questionsmedicales.fr
Cellules
Thymocytes
Thymocytes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Thymocytes
Biopsie
Tests sanguins
Imagerie par résonance magnétique
Cytologie
Thymocytes
Tests génétiques
Thymocytes
Anomalies génétiques
Fonction immunitaire
Thymocytes
Tests fonctionnels
Marqueurs cellulaires
Thymocytes
CD4
Symptômes
5
Immunodéficience
Infections
Thymocytes
Troubles auto-immuns
Lymphomes
Thymocytes
Réponse immunitaire
Thymocytes
Santé globale
Maladies immunitaires
Thymocytes
Infections récurrentes
Prévention
5
Prévention
Vaccinations
Thymocytes
Hygiène
Prévention
Thymocytes
Dépistage
Immunodéficience
Thymocytes
Nutrition
Thymocytes
Fonction immunitaire
Stress
Thymocytes
Immunité
Traitements
5
Immunosuppresseurs
Thérapie génique
Thymocytes
Transplantation
Thymus
Déficits immunitaires
Thymocytes
Traitements ciblés
Fonction immunitaire
Thérapies biologiques
Thymocytes
Réponse immunitaire
Médecine personnalisée
Thymocytes
Traitements
Complications
5
Infections
Lymphomes
Thymocytes
Troubles auto-immuns
Thymocytes
Maladies
Complications
Thymocytes
Traitements
Qualité de vie
Infections
Thymocytes
Fréquence
Complications
Thymocytes
Facteurs de risque
5
Facteurs de risque
Infections virales
Thymocytes
Maladies génétiques
Thymocytes
Risque
Mode de vie
Thymocytes
Risque
Expositions environnementales
Thymocytes
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thymocytes : Questions médicales les plus fréquentes",
"headline": "Thymocytes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thymocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thymocytes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules",
"url": "https://questionsmedicales.fr/mesh/D002477",
"about": {
"@type": "MedicalCondition",
"name": "Cellules",
"code": {
"@type": "MedicalCode",
"code": "D002477",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thymocytes",
"alternateName": "Thymocytes",
"code": {
"@type": "MedicalCode",
"code": "D060168",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lie Wang",
"url": "https://questionsmedicales.fr/author/Lie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China."
}
},
{
"@type": "Person",
"name": "Ravshan Z Sabirov",
"url": "https://questionsmedicales.fr/author/Ravshan%20Z%20Sabirov",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan."
}
},
{
"@type": "Person",
"name": "Chao Chen",
"url": "https://questionsmedicales.fr/author/Chao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China."
}
},
{
"@type": "Person",
"name": "Lin Xu",
"url": "https://questionsmedicales.fr/author/Lin%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com."
}
},
{
"@type": "Person",
"name": "Pilar López-Nieva",
"url": "https://questionsmedicales.fr/author/Pilar%20L%C3%B3pez-Nieva",
"affiliation": {
"@type": "Organization",
"name": "Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Evolving Thrombolytics: from Alteplase to Tenecteplase.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37273127",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13311-023-01391-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Thrombolysis in acute retinal ischemia treated with tenecteplase.",
"datePublished": "2024-04-05",
"url": "https://questionsmedicales.fr/article/38962669",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5693/djo.02.2023.11.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tenecteplase in Acute Stroke: What About the Children?",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37226774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/STROKEAHA.123.042951"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multicenter exploration of tenecteplase transition factors: A quantitative analysis.",
"datePublished": "2024-01-23",
"url": "https://questionsmedicales.fr/article/38266690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jstrokecerebrovasdis.2024.107592"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.",
"datePublished": "2022-07-07",
"url": "https://questionsmedicales.fr/article/35713213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ana.26445"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Thymocytes",
"item": "https://questionsmedicales.fr/mesh/D060168"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thymocytes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thymocytes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thymocytes",
"description": "Comment diagnostiquer une anomalie des thymocytes ?\nQuels examens sont utilisés pour évaluer les thymocytes ?\nLes tests génétiques sont-ils utiles pour les thymocytes ?\nPeut-on évaluer la fonction des thymocytes ?\nQuels marqueurs sont utilisés pour identifier les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thymocytes",
"description": "Quels symptômes indiquent un problème avec les thymocytes ?\nLes anomalies des thymocytes causent-elles des symptômes spécifiques ?\nComment les thymocytes affectent-ils la santé globale ?\nLes symptômes d'une maladie des thymocytes sont-ils visibles ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thymocytes",
"description": "Comment prévenir les maladies liées aux thymocytes ?\nY a-t-il des mesures préventives spécifiques ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle la santé des thymocytes ?\nLe stress a-t-il un impact sur les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thymocytes",
"description": "Quels traitements existent pour les anomalies des thymocytes ?\nLa transplantation de thymus est-elle une option ?\nLes traitements ciblent-ils spécifiquement les thymocytes ?\nLes thérapies biologiques sont-elles efficaces ?\nLes traitements sont-ils personnalisés selon le patient ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thymocytes",
"description": "Quelles complications peuvent survenir avec des thymocytes anormaux ?\nLes troubles auto-immuns sont-ils liés aux thymocytes ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thymocytes",
"description": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?\nL'âge influence-t-il le risque d'anomalies thymiques ?\nLes maladies génétiques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes expositions environnementales sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Tenecteplase#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des thymocytes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies du thymus peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les thymocytes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique et les analyses cytologiques sont courantes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les thymocytes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des anomalies génétiques affectant le développement des thymocytes."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer la fonction des thymocytes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels mesurant la réponse immunitaire peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour identifier les thymocytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD4 et CD8 sont souvent utilisés pour caractériser les thymocytes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les thymocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections fréquentes et une immunodéficience peuvent signaler des problèmes."
}
},
{
"@type": "Question",
"name": "Les anomalies des thymocytes causent-elles des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles auto-immuns et des lymphomes."
}
},
{
"@type": "Question",
"name": "Comment les thymocytes affectent-ils la santé globale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thymocytes dysfonctionnels peuvent compromettre la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une maladie des thymocytes sont-ils visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être subtils, souvent révélés par des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus marqués."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux thymocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain et des vaccinations peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les expositions aux agents pathogènes et maintenir une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surtout pour les personnes à risque d'immunodéficience."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé des thymocytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la fonction immunitaire et des thymocytes."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les thymocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction des thymocytes et l'immunité."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des thymocytes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des immunosuppresseurs et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "La transplantation de thymus est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être envisagée pour les patients avec des déficits immunitaires sévères."
}
},
{
"@type": "Question",
"name": "Les traitements ciblent-ils spécifiquement les thymocytes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements visent à restaurer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les thérapies biologiques sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent moduler la réponse immunitaire et améliorer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés selon le patient ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des thymocytes anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections graves et des cancers comme les lymphomes peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles auto-immuns sont-ils liés aux thymocytes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thymocytes dysfonctionnels peuvent contribuer à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en augmentant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être fréquentes chez les personnes avec des anomalies thymiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines infections virales augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies thymiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent prédisposer à des anomalies des thymocytes."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque d'anomalies immunitaires."
}
},
{
"@type": "Question",
"name": "Les expositions environnementales sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines expositions environnementales peuvent affecter la santé des thymocytes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Publications dans "Thymocytes" :
3 publications dans cette catégorie
Affiliations :
Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan.
Department of Biophysics, National University of Uzbekistan, Tashkent, Uzbekistan.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China.
Department of Immunology, Zunyi Medical University, Zunyi, China.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Department of Immunology, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University-University of Edinburgh Institute, Zhejiang University, Haining, China; Department of Dermatology and Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: lu_linrong@zju.edu.cn.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Department of Neurobiology and Behavior, Cornell University, Ithaca, NY, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, CA 91010.
Irell & Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA 91010.
Publications dans "Thymocytes" :
Alteplase has been the primary thrombolytic used in the treatment of acute ischemic stroke since thrombolysis was first established as an effective treatment of acute ischemic stroke in 1995. Tenectep...
Central retinal artery occlusion (CRAO), a type of acute retinal arterial ischemia, analogous to an ocular stroke, is a medical emergency that warrants immediate diagnosis and treatment. CRAO usually ...
Tenecteplase is replacing alteplase as the fibrinolytic agent of choice for the acute management of ischemic stroke in many adult stroke centers due to practical and pharmacokinetic advantages in the ...
Tenecteplase (TNK) is gaining recognition as a novel therapy for acute ischemic stroke (AIS). Despite TNK offering a longer half-life, time and cost saving benefits and comparable treatment and safety...
Identify barriers and facilitators of TNK implementation at acute care hospitals in Texas....
This prospective survey used open-ended questions and Likert statements generated from content experts and informed by qualitative research. Stroke clinicians and nurses working at 40 different hospit...
The 40 hospitals had a median of 34 (IQR 24.5-49) emergency department beds and 42.5 (IQR 23.5-64.5) inpatient stroke beds with 506.5 (IQR 350-797.5) annual stroke admissions. Fifty percent of the hos...
Understanding common barriers and facilitators to TNK adoption can assist acute care hospitals deciding to implement TNK as a treatment for AIS. These findings will be used to design a TNK adoption To...
Intravenous thrombolysis (IVT) with tenecteplase has been associated with better clinical outcomes in acute ischemic stroke (AIS) patients with confirmed large vessel occlusions compared to IVT with a...
We compared the safety and efficacy of tenecteplase versus alteplase in AIS patients by analyzing propensity score matched data from 20 centers participating in the Safe Implementation of Treatments i...
A total of 331 tenecteplase-treated AIS patients were matched to 797 patients treated with alteplase (median age = 70 years, 43.9% women, median National Institutes of Health Stroke Scale score = 11, ...
IVT with tenecteplase was associated with better 3-month clinical outcomes compared to IVT with alteplase in AIS patients, with no increased risk of symptomatic intracranial bleeding. ANN NEUROL 2022;...
Alteplase is widely used as an intravenous thrombolytic drug in acute ischemic stroke (AIS). Recently however, tenecteplase, a modified form of tissue plasminogen activator, has been shown to increase...
A Markov decision-analytic model was constructed to assess total costs, total quality-adjusted life year (QALY), an incremental cost-effectiveness ratio, and incremental net monetary benefit (INMB) of...
Treatment with tenecteplase saved €21 per patient while gaining 0.05 QALYs, resulting in INMB of €2381, clearly rendering tenecteplase cost-effective compared to alteplase. Importantly, tenecteplase r...
Tenecteplase treatment was cost-effective for all AIS patients (including AIS patients with LVO) compared to alteplase. The finding supports the broader use of tenecteplase in acute stroke care, as he...
Reperfusion is critical for improving outcomes of patients experiencing ischemic stroke. Increasing evidence supports tenecteplase as an alternative to alteplase, with many potential benefits. This ar...
The New Zealand (NZ) Central Region Stroke Network, serving 1.17 million catchment population, changed to tenecteplase for stroke thrombolysis in 2020 but was forced to revert to Alteplase in 2021 due...
In NZ all reperfused patients are entered prospectively into a national database for safety monitoring. We assessed Central Region patient outcomes and treatment metrics over three time periods: altep...
Between January 2018 and December 2022, we treated 1121 patients with Alteplase and 286 with tenecteplase. Overall, patients treated with tenecteplase had greater odds of favorable outcome ordinal mRS...
Our results suggest that previously reported benefits from tenecteplase in a real-world setting were not likely attributable to a temporal confounding....
Intravenous thrombolysis with alteplase has been the foundation of initial treatment of acute ischemic stroke for several decades. Tenecteplase is a thrombolytic agent that offers logistical advantage...
In this retrospective study using the US cohort of 54 academic medical centers/health care organizations in the TriNetX database, we identified 3,432 patients treated with tenecteplase and 55,894 pati...
Patients treated with tenecteplase had a significantly lower mortality rate (8.2% versus 9.8%; risk ratio [RR], 0.832) and lower risk of major bleeding as measured by the frequency of blood transfusio...
In our large retrospective multicenter study using real-world evidence from large health care organizations, tenecteplase for the treatment of acute stroke demonstrated a lower mortality rate, decreas...
Tenecteplase improves reperfusion compared to alteplase in patients with large vessel occlusions. To determine whether this improvement varies across the spectrum of thrombolytic agent to reperfusion ...
Patients with large vessel occlusion and treatment with thrombolysis were pooled from the Melbourne Stroke Registry, and the EXTEND-IA and EXTEND-IA TNK trials. The primary outcome, thrombolytic-induc...
Among 893 patients included in the primary analysis, thrombolytic-induced reperfusion was observed in 184 (21%) patients. Tenecteplase was associated with higher rates of reperfusion (adjusted inciden...
Tenecteplase, compared to alteplase, increases prethrombectomy reperfusion, regardless of the time from administration to reperfusion assessment. Prethrombectomy reperfusion is associated with better ...